These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 22516406)

  • 1. More positive fluid balance could explain lower risk of contrast nephropathy.
    Chauhan V
    JACC Cardiovasc Interv; 2012 Apr; 5(4):454; author reply 455-6. PubMed ID: 22516406
    [No Abstract]   [Full Text] [Related]  

  • 2. Hydration is critical for prevention of contrast-induced nephropathy.
    Sharma D
    JACC Cardiovasc Interv; 2012 Apr; 5(4):454-5; author reply 455-6. PubMed ID: 22516407
    [No Abstract]   [Full Text] [Related]  

  • 3. Prevention of contrast nephropathy by furosemide with matched hydration: the MYTHOS (Induced Diuresis With Matched Hydration Compared to Standard Hydration for Contrast Induced Nephropathy Prevention) trial.
    Marenzi G; Ferrari C; Marana I; Assanelli E; De Metrio M; Teruzzi G; Veglia F; Fabbiocchi F; Montorsi P; Bartorelli AL
    JACC Cardiovasc Interv; 2012 Jan; 5(1):90-7. PubMed ID: 22230154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiology Grand Rounds from The University of North Carolina at Chapel Hill. Contrast induced nephropathy after angiography.
    Agrawal M; Stouffer GA
    Am J Med Sci; 2002 May; 323(5):252-8. PubMed ID: 12018667
    [No Abstract]   [Full Text] [Related]  

  • 5. Acute Kidney Injury With the RenalGuard System in Patients Undergoing Transcatheter Aortic Valve Replacement: The PROTECT-TAVI Trial (PROphylactic effecT of furosEmide-induCed diuresis with matched isotonic intravenous hydraTion in Transcatheter Aortic Valve Implantation).
    Barbanti M; Gulino S; Capranzano P; Immè S; Sgroi C; Tamburino C; Ohno Y; Attizzani GF; Patanè M; Sicuso R; Pilato G; Di Landro A; Todaro D; Di Simone E; Picci A; Giannetto G; Costa G; Deste W; Giannazzo D; Grasso C; Capodanno D; Tamburino C
    JACC Cardiovasc Interv; 2015 Oct; 8(12):1595-604. PubMed ID: 26386766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic strategies to prevent contrast-induced acute kidney injury.
    Quintavalle C; Donnarumma E; Fiore D; Briguori C; Condorelli G
    Curr Opin Cardiol; 2013 Nov; 28(6):676-82. PubMed ID: 24077605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contrast medium-induced acute renal failure. Can it be prevented?
    Golman K; Cederholm C
    Invest Radiol; 1990 Sep; 25 Suppl 1():S127-8. PubMed ID: 2126532
    [No Abstract]   [Full Text] [Related]  

  • 8. A randomized trial of saline hydration to prevent contrast-induced nephropathy in patients on regular captopril or furosemide therapy undergoing percutaneous coronary intervention.
    Shemirani H; Pourrmoghaddas M
    Saudi J Kidney Dis Transpl; 2012 Mar; 23(2):280-5. PubMed ID: 22382219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Contrast medium induced nephropathy: pathogenesis, clinical aspects, prevention].
    Haller C; Kübler W
    Dtsch Med Wochenschr; 1999 Mar; 124(11):332-6. PubMed ID: 10209535
    [No Abstract]   [Full Text] [Related]  

  • 10. Contrast-associated nephropathy--old clinical problem and new therapeutic perspectives.
    Kolonko A; Kokot F; Wiecek A
    Nephrol Dial Transplant; 1998 Mar; 13(3):803-6. PubMed ID: 9550679
    [No Abstract]   [Full Text] [Related]  

  • 11. Potential deleterious effect of furosemide in radiocontrast nephropathy.
    Weinstein JM; Heyman S; Brezis M
    Nephron; 1992; 62(4):413-5. PubMed ID: 1300436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contrast-associated Acute Kidney Injury.
    Weisbord SD; Palevsky PM
    Crit Care Clin; 2015 Oct; 31(4):725-35. PubMed ID: 26410140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiocontrast-induced nephropathy. Prevention is better than cure.
    Mehra MR; Sharif K; Bode FR
    Postgrad Med; 1992 Dec; 92(8):215-8, 222-3. PubMed ID: 1454669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Protecting kidneys from radiocontrast toxicity--do fluids or drugs help?].
    Aitio ML
    Duodecim; 1999; 115(19):2075-84. PubMed ID: 11941801
    [No Abstract]   [Full Text] [Related]  

  • 15. Forced diuresis with the RenalGuard system: impact on contrast induced acute kidney injury.
    Solomon R
    J Cardiol; 2014 Jan; 63(1):9-13. PubMed ID: 24239195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of human atrial natriuretic peptide and furosemide on glomerular filtration rate and renal oxygen consumption in humans.
    Swärd K; Valsson F; Sellgren J; Ricksten SE
    Intensive Care Med; 2005 Jan; 31(1):79-85. PubMed ID: 15565364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal insufficiency following contrast media administration trial II (REMEDIAL II): RenalGuard system in high-risk patients for contrast-induced acute kidney injury: rationale and design.
    Briguori C; Visconti G; Ricciardelli B; Condorelli G;
    EuroIntervention; 2011 Apr; 6(9):1117-22, 7. PubMed ID: 21518686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Intraoperative Aminophylline Versus Furosemide in Treatment of Oliguria During Pediatric Cardiac Surgery.
    Onder AM; Rosen D; Mullett C; Cottrell L; Kanosky S; Grossman OK; Iqbal HI; Seachrist E; Samsell L; Gustafson K; Rhodes L; Gustafson R
    Pediatr Crit Care Med; 2016 Aug; 17(8):753-63. PubMed ID: 27355823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute kidney injury.
    Reis T
    Rev Assoc Med Bras (1992); 2020 Jan; 66Suppl 1(Suppl 1):s68-s74. PubMed ID: 31939538
    [No Abstract]   [Full Text] [Related]  

  • 20. A randomized trial of saline hydration to prevent contrast nephropathy in chronic renal failure patients.
    Dussol B; Morange S; Loundoun A; Auquier P; Berland Y
    Nephrol Dial Transplant; 2006 Aug; 21(8):2120-6. PubMed ID: 16611682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.